News - "Positive Proof of Concept"Avivagen Reports Positive Proof of Concept in Preventing C. Difficile Infection OTTAWA, April 10, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (VIV.V) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces positive results from a proof-of-concept study that could extend Avivagen’s OxC-beta™ technology into human health applications....
Read More at:
https://finance.yahoo.com/news/avivagen-reports-positive-proof-concept-114330077.html